TAC1 and depressive symptom measurement: This is supported by the observation that the central administration of Substance P and NK-1R (neurokinin type 1 receptor) leads to depression-like and anxious behaviors in animals, while NK-1R antagonists cause a decrease in c-Fos expression in PVN along with an anxiolytic effect [249,250].